Literature DB >> 23049306

Iron deficiency anemia and its treatment - reply.

Rodolfo Delfini Cançado1.   

Abstract

Entities:  

Year:  2011        PMID: 23049306      PMCID: PMC3415746          DOI: 10.5581/1516-8484.20110064

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN: 1516-8484


× No keyword cloud information.
From a practical standpoint, it is recommendable to adopt some measures in order to succeed in minimizing the adverse events and improve adherence to oral iron supplementation treatment, such as splitting the recommended daily dose in two or three smaller doses, counseling the patient to take the medication during or after meals (in these cases, the reduction in the amount of iron absorbed can be offset by increased adherence and duration of treatment) and initiating therapy with doses lower than recommended, i.e. 40 to 80 mg/day and gradually increase them, depending on the tolerance of the patient.( It is well known that when administering daily doses of elemental iron below 60 mg, the frequency and intensity of adverse events observed are similar between individuals taking placebo and iron salts. Thus, clinical studies have used iron sulfate in different treatment regimens such as: 25 mg of elemental iron once per week;( 60 mg of elemental iron once daily or twice per week;( and 60 mg of elemental iron once weekly or once per day.( The results clearly demonstrated that adherence is better when using smaller doses at longer intervals, however, the therapeutic success is not what was expected or the time required to achieve the expected result is much longer (weeks or months). Undoubtedly, an intermittent administration of oral iron should be recommended as a way of improving treatment compliance and reduce dropout rates to treatment, especially in pregnant women. Also elderly patients have a higher incidence of adverse events when treated with oral iron at the recommended therapeutic dose. In these cases, lower doses, even 15 mg of elemental iron per day may be effective in cases of mild anemia due to lower adverse events.(
  5 in total

1.  [Use of daily and weekly ferrous sulfate to treat anemic childbearing-age women].

Authors:  M C Lopes; L O Ferreira; M Batista Filho
Journal:  Cad Saude Publica       Date:  1999 Oct-Dec       Impact factor: 1.632

2.  Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate.

Authors:  M Coplin; S Schuette; G Leichtmann; B Lashner
Journal:  Clin Ther       Date:  1991 Sep-Oct       Impact factor: 3.393

3.  Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form.

Authors:  L Hallberg; L Ryttinger; L Sölvell
Journal:  Acta Med Scand Suppl       Date:  1966

4.  Are we giving too much iron? Low-dose iron therapy is effective in octogenarians.

Authors:  Ephraim Rimon; Nadya Kagansky; Michael Kagansky; Lora Mechnick; Tony Mashiah; Michael Namir; Shmuel Levy
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

Review 5.  Individualized treatment for iron-deficiency anemia in adults.

Authors:  Michael Alleyne; McDonald K Horne; Jeffery L Miller
Journal:  Am J Med       Date:  2008-11       Impact factor: 4.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.